News
- 2025/12/12
- Noile-Immune’s President & CEO, Koji Tamada, MD, Ph.D. (Director, Research Institute for Cell Design Medical Science, Yamaguchi University / Professor, Department of Immunology, Yamaguchi University Graduate School of Medicine), presented the latest strategies for CAR-T cell therapy against solid tumors and Noile-Immune’s developed technologies at the 54th Annual Meeting of the Japanese Society for Immunology (from Wednesday, December 10 to Friday, December 12, 2025 in Himeji City, Hyogo Prefecture).
- Meeting：The 54th Annual Meeting of the Japanese Society for Immunology (December 10-12, 2025, in Himeji City, Hyogo Prefecture)
- Date and time：8:30～11:30, Friday, December 12, 2025
- Session：S11, Current Status and Prospects of Cell Therapy
- Presentation Title: Novel strategies to improve the anti-tumor potential of CAR-T cells against solid cancers
- Speaker: Koji Tamada, MD, Ph.D. (President & CEO, Noile-Immune Biotech Inc. / Director, Research Institute for Cell Design Medical Science, Yamaguchi University / Professor, Department of Immunology, Yamaguchi University Graduate School of Medicine)
- 2025/12/05
- Noile-Immune’s Adviser, Yukimi Sakoda, M.D., Ph.D. (Associate Professor, Department of Immunology, Yamaguchi University Graduate School of Medicine), presented the research achievement of short-term manufacturing method for CAR-T at the 48th Annual Meeting of the Molecular Biology Society of Japan (from Wednesday, December 3 to Friday, December 5, 2025 at Pacifico Yokohama).
- Meeting：48th Annual Meeting of the Molecular Biology Society of Japan (December 3-5, 2025, at Pacifico Yokohama)
- Date and time：9:00～11:00, Thursday, December 4, 2025
- Session：Symposium [2AS-10] Beyond CAR-T: Pioneering New Horizons in Designer Cell Technology
- Presentation Title: Improvement of CAR-T cell manufacturing method to enhance antitumor efficacy against solid cancer
- Speaker: Yukimi Sakoda, M.D., Ph.D. (Adviser, Noile-Immune Biotech Inc. / Associate Professor, Department of Immunology, Yamaguchi University Graduate School of Medicine)
- 2025/11/19
- Registration of a Patent related to Noile-Immune's Developed Technology Completed in Japan
- 2025/11/07
- Noile-Immune announces that Keishi Adachi, D.V.M., Ph.D., Associate Professor of Yamaguchi University which is conducting joint research with Noile-Immune, presented the data on allogeneic CAR-T cell therapy with PRIME technology in the session “Frontiers in Tumor Immunology” at the 38th Annual Meeting of the Japanese Society for Biological Therapy (November 6-7, 2025, in Yamaguchi City, Yamaguchi Prefecture).
- Meeting: 38th Annual Meeting of the Japanese Society for Biological Therapy (November 6-7, 2025, in Yamaguchi City, Yamaguchi Prefecture)
- Session: Frontiers in Tumor Immunology
- Presentation title: Development of Next-generation CAR-T Cell Therapy for Solid Tumors based on Epitope Spreading
- Presenter: Keishi Adachi, D.V.M., Ph.D., Associate Professor (Department Immunology, Yamaguchi University Graduate School of Medicine / Research Institute for Cell Design Medical Science, Yamaguchi University)
- 2025/10/01
- Noile-Immune’s President & CEO, Koji Tamada, MD, Ph.D., will give a seminar presentation at BioJapan2025 (from Wednesday, October 8 to Friday, October 10 at PACIFICO Yokohama).
- ・Date and time: Wednesday, October 8, 2025, 14:00–15:00
・Venue： Annex Hall F202, PACIFICO Yokohama
・Seminar: Sponsor Seminar; Takara Bio, Endeavor and future perspective in research and development of novel CAR-T technologies
・Presentation title: Endeavor and future perspective in research and development of novel CAR-T technologies
・Presenter: Koji Tamada MD, Ph.D. (Professor at Graduate School of Medicine / Director at Research Institute for Cell Design Medical Science, Yamaguchi University)
Information on the seminars is here. (BioJapan2025 site)